Daniel Suez, MD
Allergy & Immunology · Irving, TXNPI 1255312773
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 16.6%. Among allergy & immunology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 537 payments — averaging $145.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$13K
- CSL Behring$13K
- Teva Pharmaceuticals USA, Inc.$8K
- Blueprint Medicines Corporation$8K
- Pharming Healthcare, Inc.$6K
- Takeda Pharmaceuticals U.S.A., Inc.$5K
- plus $26K from 35 others
Across 103 payments — averaging $3217.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Grifols Therapeutics LLC$146K
- Takeda Pharmaceuticals U.S.A., Inc.$105K
- ADMA Biomanufacturing LLC$44K
- Biocryst Pharmaceuticals, Inc.$12K
- Octapharma USA, Inc.$12K
- Grifols Biologicals LLC$9K
- plus $4K from 1 others
Across 2 payments — averaging $2603.50 each. An ownership or investment interest held by the physician or an immediate family member.
- Consortium Of Independent Immunology Clinics, LLC$5K
What the payments were for
- Consulting fees$12,92816%
- Speaking & faculty fees$43,55856%
- Travel & lodging$2,4153%
- Food & beverage$14,91919%
- Education$1530%
- Gifts$4,1905%
- Other$2340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$78,396 in reported general payments places this provider in the 95th percentile of 336 allergy & immunology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azithromycin | 25 | $107 |
| Montelukast Sodium | 17 | $68 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Irving
- Joseph DiazSan Antonio$1.1M
- Richard WassermanDallas$452K
- Matthew FeldmanDallas$410K
- Lukena KarkhanisSan Antonio$377K
- Paul VigoAustin$304K
- Neha ReshamwalaAustin$303K
- Lara GrossDallas$171K
- Bobby LanierBenbrook$149K
- Juan ZambranoHouston$146K
- Serge de GolovineBellaire$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.